Peter Loftus
Wall Street Journal @WSJ reporter - drugs, medical devices, healthcare. 215-881-7127, [email protected]
Last synced from Twitter 9m ago
DNA Testing Creates Wrenching Dilemmas for the Family Historian
With home testing now ubiquitous, keepers of the family tree are forced to juggle the privacy of close relatives with the needs of newly discovered kin; “I am sorry my doing genealogy has opened up Pandora’s box.”
Johnson & Johnson Faces Key Test in Defense Against Talc-Safety Lawsuits
Johnson & Johnson, still facing thousands of lawsuits over the safety of its signature baby powder, will make a high-stakes attempt to head off future losses in a courtroom battle beginning Monday.
1
Peter Loftus
Baby-powder maker Johnson & Johnson will attempt to prevent future losses from thousands of talc lawsuits in a hearing slated to begin on Monday wsj.com/articles/johns… via @WSJ w/ @sara_randazzo
11h
Delaware Bay's spring sex party
Horseshoe crabs breed along North America’s eastern coast, from Maine to Mexico. Every year, tens of thousands of them hook up at the Jersey Shore.
Novartis Sets Aside $700 Million to Settle Bribery Allegations
Swiss drugmaker Novartis set aside $700 million to settle a long-running lawsuit alleging it treated U.S. doctors to lavish dinners and other events in return for boosting prescriptions.
CVS Begins Clinical Trial for Home-Dialysis Device
CVS is making a move into kidney care, launching a clinical trial for a home-dialysis device. The company is working to capitalize on a Trump administration initiative pushing for home procedures.
Rising health insurance deductibles fuel middle-class anger and resentment
Middle-class Americans are bearing the brunt of the rise in health insurance deductibles and medical bills. That's helped widen the country's political divisions.
Apollo 11 Had a Hidden Hero: Software
The moon landing was one of the most important moments in the history of computing, laying the foundations for everything from fly-by-wire cockpits to the smartphones in our hands.
OxyContin Made The Sacklers Rich. Now It’s Tearing Them Apart.
The billionaire family was so fractious one member tried to punch another in a board meeting. More recently, a rash of lawsuits, which accuse its Purdue Pharma of helping fuel the addiction crisis, has exacerbated these longstanding divisions and...
Peter Loftus
“This situation is destroying our work, our friendships, our reputation and our ability to function in society.” The family behind OxyContin is brawling with itself. wsj.com/articles/oxyco… via @WSJ
6d
Fast-Track Drug Approval, Designed for Emergencies, Is Now Routine
Three-quarters of new drugs get an expedited regulatory review, a process that offers a measure of hope to critically ill patients. It also thrusts families and doctors into a new world of trade-offs, raising questions about the value of drugs with...
Peter Loftus
Drugs for diseases including cancer are coming to market faster than ever. A rising proportion lack extensive evidence they can prolong lives. wsj.com/articles/fast-… via @WSJ
6d
Don’t Understand Moronic Bromides (in Scientific Acronyms)?
You aren’t alone. There is a whole wing of research showing those clever names for inventions and medical studies just confuse everyone.
Do Hand Dryers Hurt Kids’ Hearing? This 13-Year-Old Studied It
Nora Keegan noticed that dryers tended to be closer to children’s ears. So she set out on a study that was eventually published in a medical journal in Canada.
Philadelphia’s Hahnemann University Hospital Files for Bankruptcy
The owners of Hahnemann University Hospital, a historic, money-losing teaching hospital in Philadelphia, filed for bankruptcy after failed efforts to find a buyer and a closure announcement that triggered street protests and warnings from state...
FDA warns patients and health care providers about potential cybersecurity concerns with certain Medtronic insulin pumps
FDA is warning patients and providers that certain Medtronic MiniMed insulin pumps are being recalled due to potential cybersecurity risks
Drugs make headway against lung, breast, prostate cancers
CHICAGO (AP) — Newer drugs are substantially improving the chances of survival for some people with hard-to-treat forms of lung, breast and prostate cancer, doctors reported at the world's largest...
At $2.1 Million, New Gene Therapy Is The Most Expensive Drug Ever
The Food and Drug Administration approved a new gene therapy for a rare but devastating genetic disorder. The drugmaker says the cost is worth it because it's a one-time treatment that saves lives.
ACLU sues Corrections over denial of hepatitis C treatment
The standard curative medication, a daily oral pill taken for eight to 12 weeks, is allegedly being withheld from more than 200 prisoners so the DOC can cut costs.
Hearing on “Priced Out of a Lifesaving Drug: Getting Answers on the Rising Cost of Insulin”
The Oversight and Investigations Subcommittee will hold a hearing on Wednesday, April 10, at 10:30 am in 2322 of the Rayburn House Office Building. The hearing is entitled, “Priced Out of a Lifesaving Drug: Getting Answers on the Rising Cost of...
Why Investors Are Obsessed With the Inverted Yield Curve
Amid a shaky marketplace, investors are eyeing the yield curve for signs of economic stability. History shows that when the yield curve inverts, a recession may soon follow. Photo Composite: Stephanie Swart for The Wall Street Journal.
Peter Loftus
Good explainer video on a bad economic omen: Why Investors Are Obsessed With the Inverted Yield Curve
119d